Clinical trial
A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
NCT00035828 is registered in ClinicalTrials.gov with Abgenix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
- Lead sponsor
- Abgenix
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2001
- Completion date
- December 31, 2002
- Enrollment
- 150
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.